Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-071811
Filing Date
2024-06-14
Accepted
2024-06-14 16:49:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm2416818-4_424b5.htm 424B5 736950
2 GRAPHIC lg_rezolute-4clr.jpg GRAPHIC 8231
3 GRAPHIC lc_exemplary-4clr.jpg GRAPHIC 106695
4 GRAPHIC tb_treatment-4clr.jpg GRAPHIC 137568
5 GRAPHIC lc_primary-4clr.jpg GRAPHIC 77108
6 GRAPHIC bc_participant-4clr.jpg GRAPHIC 85407
  Complete submission text file 0001104659-24-071811.txt   1305420
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-275562 | Film No.: 241045614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)